NSTG NanoString Technologies

NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares

NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares
EN
13/10/2020

Underlying

NSTGNanoString Technologies

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NanoString Technologies

 PRESS RELEASE
Free
NSTG NanoString Tech...

NanoString Reports Inducement Grants Under Nasdaq Listing Rules

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 10 new employees. In accordance with Nasdaq Listing Rule 5635(c)(4), on December 6, 2023, the Compensation and Human Capital Committee of NanoString’s Board of Directors approved the grant of, in the aggregate, 34,925 restricted stock units, or RSUs, as material inducements to the 10 employees entering into employment with NanoString. One-third of the R...

January 5, 2024 1 EN
 PRESS RELEASE
Free
NSTG NanoString Tech...

NanoString to Webcast Presentation from 42nd Annual J.P. Morgan Health...

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 42nd annual J.P. Morgan healthcare conference, being held January 8-11, 2024. Brad Gray, president and chief executive officer, is scheduled to present on Wednesday, January 10, at 5:15pm ET. Interested parties can access the live webcast from the investor section of the company’s website at . The webcast replay will be available one hour after the conc...

January 4, 2024 1 EN
 PRESS RELEASE
Free
NSTG NanoString Tech...

NanoString Comments on Delaware District Court Verdict

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, commented on the November 17th verdict of a jury in the U.S. District Court for the District of Delaware finding that NanoString GeoMx® Digital Spatial Profiler products infringe patents licensed to 10x Genomics and awarding approximately $31 million in damages, consisting of approximately $25 million of lost profits and a $6 million royalty. “We respectfully disagree with the jury’s verdict, which we will seek to have overturned or amend...

November 19, 2023 1 EN
 PRESS RELEASE
Free
NSTG NanoString Tech...

NanoString to Webcast Presentations from Upcoming Healthcare Conferenc...

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. Stifel 2023 Healthcare Conference Tuesday, November 14th Tom Bailey, NanoString’s chief financial officer, and Doug Farrell, VP of Investor Relations, will participate in a fireside discussion hosted by Stifel analyst Dan Arias at 9:45am ET. Jefferies London Healthcare Conference Thursday, November 16th Tom Bailey, Nano...

November 9, 2023 1 EN
 PRESS RELEASE
Free
NSTG NanoString Tech...

NanoString Technologies Releases Operating Results for Third Quarter o...

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter ended September 30, 2023. The Company also announced it had reached agreement with holders to exchange approximately $216 million, or 94%, principal amount of its Convertible Notes for new Senior Secured Notes due September 1, 2026 and common stock warrants. “The last few months have been extraordinarily productive for our team. During the third quarter, we delivered record revenue whi...

November 6, 2023 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch